{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-042911","form_type":"8-K","ticker":"OCEA","cik":"0001869974","company_name":"Ocean Biomedical, Inc.","filed_at":"2024-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.193787+00:00","generated_at":"2026-05-30T09:24:30.988666+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CEO Elizabeth Ng takes sabbatical; Director M. Michelle Berrey appointed Interim CEO","bullets":["Elizabeth Ng notified Board on Oct 23, 2024 of sabbatical for personal reasons.","Director M. Michelle Berrey appointed Interim CEO, effective immediately.","Compensation arrangements for Interim CEO not yet determined; will be disclosed later."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-042911","json":"https://secwatch.observer/filing/0001493152-24-042911.json","markdown":"https://secwatch.observer/filing/0001493152-24-042911.md","text":"https://secwatch.observer/filing/0001493152-24-042911.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1869974/000149315224042911/0001493152-24-042911-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1869974/000149315224042911/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T09:24:30.988666+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2c9a1a3cd2","claim":"Elizabeth Ng departed as Chief Executive Officer at Ocean Biomedical, Inc..","evidence_excerpt":"On October 23, 2024, Elizabeth Ng notified the Company’s Board of Directors that she would be taking a sabbatical for personal reasons.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1869974/000149315224042911/0001493152-24-042911-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"took a sabbatical"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"7fdf6bc70e","claim":"M. Michelle Berrey was appointed as Interim Chief Executive Officer at Ocean Biomedical, Inc..","evidence_excerpt":"Director, M. Michelle Berrey was appointed to act as Interim Chief Executive Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1869974/000149315224042911/0001493152-24-042911-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}